Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Finasteride increases hair count in middle-aged and elderly men without causing sexual dysfunction.

Oral ivermectin effectively cured scabies with minimal side effects, and finasteride promoted hair growth in men with hair loss.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

The study concluded that specific proteins are necessary to maintain the structure that holds epithelial cells tightly together.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

The G60S Connexin43 mutation causes hair growth issues and poor hair quality in mice, similar to human ODDD patients.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in patients with Tourette syndrome.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

A woman with severe angioedema improved significantly after treatment with rituximab.

The monkey's hair loss was due to an autoimmune disease, not genetics.

P-cadherin is important for hair growth and health, and its problems can cause hair and skin disorders.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

Skin problems can be signs of hormone-related disorders and recognizing them early is important for treatment.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

Collagen XVII is important for skin aging and wound healing.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

The new automatic tool accurately measures hair thickness and is reliable.

Plant-based ingredients in hair care are being replaced by synthetic alternatives.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.